| Name | tert-butyl 4-[4-(hydroxymethyl)phenyl]piperazine-1-carboxylate |
|---|---|
| Synonyms |
TERT-BUTYL 4-[4-(HYDROXYMETHYL)PHENYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE
1-hydroxymethyl-4-(4-(1,1-dimethylethoxycarbonyl)piperazinyl)benzene 1-(tert-Butoxycarbonyl)-4-(4-hydroxymethylphenyl)piperazine 4-(4-N-Boc-piperazinyl)benzyl alcohol tert-Butyl 4-(4-(hydroxymethyl)phenyl)piperazine-1-carboxylate |
| Density | 1.152g/cm3 |
|---|---|
| Boiling Point | 452ºC at 760mmHg |
| Melting Point | 109ºC |
| Molecular Formula | C16H24N2O3 |
| Molecular Weight | 292.37300 |
| Flash Point | 227.2ºC |
| Exact Mass | 292.17900 |
| PSA | 53.01000 |
| LogP | 2.23890 |
| Vapour Pressure | 5.86E-09mmHg at 25°C |
| Index of Refraction | 1.553 |
| Hazard Codes | Xi: Irritant; |
|---|---|
| HS Code | 2933599090 |
|
~88%
158985-37-6 |
| Literature: VERTEX PHARMACEUTICALS INCORPORATED Patent: WO2007/27528 A2, 2007 ; Location in patent: Page/Page column 47-48 ; WO 2007/027528 A2 |
|
~75%
158985-37-6 |
| Literature: Merck Sharpe and Dohme Ltd. Patent: US5432177 A1, 1995 ; |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |